Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Metastatic Brain Tumours Using Dynamic Glucose Enhanced MRI After D-glucose Injection

NCT02796729 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT02796729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02796729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Metastatic Brain Tumours Using Dynamic Glucose Enhanced MRI After D-glucose Injection
Lead sponsor
British Columbia Cancer Agency
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2016
Completion date
December 31, 2018
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain neoplasms, malignant, metastasis